CA2383725A1 - Procede de determination d'analytes au moyen d'un spectre en proche infrarouge, d'un spectre visible adjacent et de longueurs d'ondes distinctes de spectre en proche infrarouge - Google Patents
Procede de determination d'analytes au moyen d'un spectre en proche infrarouge, d'un spectre visible adjacent et de longueurs d'ondes distinctes de spectre en proche infrarouge Download PDFInfo
- Publication number
- CA2383725A1 CA2383725A1 CA002383725A CA2383725A CA2383725A1 CA 2383725 A1 CA2383725 A1 CA 2383725A1 CA 002383725 A CA002383725 A CA 002383725A CA 2383725 A CA2383725 A CA 2383725A CA 2383725 A1 CA2383725 A1 CA 2383725A1
- Authority
- CA
- Canada
- Prior art keywords
- radiation
- measurements
- discrete
- wavelengths
- nir region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 71
- 238000001429 visible spectrum Methods 0.000 title description 4
- 238000005259 measurement Methods 0.000 claims abstract description 104
- 230000005855 radiation Effects 0.000 claims abstract description 83
- 239000000470 constituent Substances 0.000 claims abstract description 38
- 238000001228 spectrum Methods 0.000 claims abstract description 28
- 210000004369 blood Anatomy 0.000 claims abstract description 25
- 239000008280 blood Substances 0.000 claims abstract description 25
- 230000001678 irradiating effect Effects 0.000 claims abstract description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 16
- 239000008103 glucose Substances 0.000 claims description 16
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- 238000002835 absorbance Methods 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 description 20
- 230000009102 absorption Effects 0.000 description 15
- 238000010521 absorption reaction Methods 0.000 description 15
- 239000012491 analyte Substances 0.000 description 14
- 230000006872 improvement Effects 0.000 description 14
- 238000013459 approach Methods 0.000 description 8
- 210000000624 ear auricle Anatomy 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 238000005286 illumination Methods 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 239000010703 silicon Substances 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- -1 creative Chemical compound 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- AQLMHYSWFMLWBS-UHFFFAOYSA-N arsenite(1-) Chemical compound O[As](O)[O-] AQLMHYSWFMLWBS-UHFFFAOYSA-N 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012306 spectroscopic technique Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Emergency Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15153799P | 1999-08-31 | 1999-08-31 | |
| US60/151,537 | 1999-08-31 | ||
| PCT/CA2000/001000 WO2001016577A1 (fr) | 1999-08-31 | 2000-08-31 | Procede de determination d'analytes au moyen d'un spectre en proche infrarouge, d'un spectre visible adjacent et de longueurs d'ondes distinctes de spectre en proche infrarouge |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2383725A1 true CA2383725A1 (fr) | 2001-03-08 |
Family
ID=22539212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002383725A Abandoned CA2383725A1 (fr) | 1999-08-31 | 2000-08-31 | Procede de determination d'analytes au moyen d'un spectre en proche infrarouge, d'un spectre visible adjacent et de longueurs d'ondes distinctes de spectre en proche infrarouge |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1214577A1 (fr) |
| JP (1) | JP2003508744A (fr) |
| CA (1) | CA2383725A1 (fr) |
| WO (1) | WO2001016577A1 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6591122B2 (en) * | 2001-03-16 | 2003-07-08 | Nellcor Puritan Bennett Incorporated | Device and method for monitoring body fluid and electrolyte disorders |
| US7239902B2 (en) | 2001-03-16 | 2007-07-03 | Nellor Puritan Bennett Incorporated | Device and method for monitoring body fluid and electrolyte disorders |
| US8135448B2 (en) | 2001-03-16 | 2012-03-13 | Nellcor Puritan Bennett Llc | Systems and methods to assess one or more body fluid metrics |
| US7657292B2 (en) | 2001-03-16 | 2010-02-02 | Nellcor Puritan Bennett Llc | Method for evaluating extracellular water concentration in tissue |
| GB2382406B (en) * | 2001-08-02 | 2005-04-20 | Electrode Company Ltd | Analytical apparatus |
| JP2005253478A (ja) * | 2002-03-18 | 2005-09-22 | Citizen Watch Co Ltd | ヘモグロビン分析装置 |
| CN100406872C (zh) * | 2002-11-04 | 2008-07-30 | 天津市先石光学技术有限公司 | 复合光谱测量方法及其光谱检测仪器 |
| US20060234386A1 (en) * | 2003-04-30 | 2006-10-19 | Mcgill University | Method and system for measuring lactate levels in vivo |
| US7277741B2 (en) | 2004-03-09 | 2007-10-02 | Nellcor Puritan Bennett Incorporated | Pulse oximetry motion artifact rejection using near infrared absorption by water |
| WO2006000911A1 (fr) * | 2004-06-23 | 2006-01-05 | Alec Blanchard | Appareil d'analyse d'elements tissulaires et sanguins |
| EP1897486A1 (fr) * | 2006-09-11 | 2008-03-12 | FOSS Analytical AB | Dispositif de surveillance optique de substances sanguines à analyser |
| US7869850B2 (en) | 2005-09-29 | 2011-01-11 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
| US8180419B2 (en) | 2006-09-27 | 2012-05-15 | Nellcor Puritan Bennett Llc | Tissue hydration estimation by spectral absorption bandwidth measurement |
| US8116852B2 (en) | 2006-09-29 | 2012-02-14 | Nellcor Puritan Bennett Llc | System and method for detection of skin wounds and compartment syndromes |
| CA2664691A1 (fr) | 2006-09-29 | 2008-04-03 | Ottawa Health Research Institute | Technique de correlation pour l'analyse d'un etat clinique |
| US8346327B2 (en) | 2007-03-09 | 2013-01-01 | Covidien Lp | Method for identification of sensor site by local skin spectrum data |
| US8690864B2 (en) | 2007-03-09 | 2014-04-08 | Covidien Lp | System and method for controlling tissue treatment |
| US8109882B2 (en) | 2007-03-09 | 2012-02-07 | Nellcor Puritan Bennett Llc | System and method for venous pulsation detection using near infrared wavelengths |
| US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
| US8357090B2 (en) | 2007-03-09 | 2013-01-22 | Covidien Lp | Method and apparatus for estimating water reserves |
| US8175665B2 (en) | 2007-03-09 | 2012-05-08 | Nellcor Puritan Bennett Llc | Method and apparatus for spectroscopic tissue analyte measurement |
| JP5303851B2 (ja) * | 2007-04-03 | 2013-10-02 | 株式会社島津製作所 | 飲酒検知装置 |
| US9895068B2 (en) | 2008-06-30 | 2018-02-20 | Covidien Lp | Pulse oximeter with wait-time indication |
| ES2335565B1 (es) | 2008-09-26 | 2011-04-08 | Hanscan Ip, B.V. | Sistema optico, procedimiento y programa de ordenador para detectar la presencia de un elemento biologico vivo. |
| JP5552819B2 (ja) * | 2010-01-28 | 2014-07-16 | ソニー株式会社 | 濃度測定装置 |
| JPWO2018194056A1 (ja) * | 2017-04-18 | 2020-02-27 | 興和株式会社 | 血液の吸収スペクトルを算出する情報処理方法、情報処理装置およびプログラム |
| JP7182887B2 (ja) * | 2018-03-27 | 2022-12-05 | キヤノン株式会社 | 生体情報測定装置および生体情報測定方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672875A (en) * | 1992-07-15 | 1997-09-30 | Optix Lp | Methods of minimizing scattering and improving tissue sampling in non-invasive testing and imaging |
| US5818048A (en) * | 1992-07-15 | 1998-10-06 | Optix Lp | Rapid non-invasive optical analysis using broad bandpass spectral processing |
| HU216847B (hu) * | 1995-05-23 | 1999-12-28 | Gyula Domján | Eljárás és berendezés vérösszetétel-paraméterek gyors noninvazív meghatározására |
| US5743262A (en) * | 1995-06-07 | 1998-04-28 | Masimo Corporation | Blood glucose monitoring system |
| US5747806A (en) * | 1996-02-02 | 1998-05-05 | Instrumentation Metrics, Inc | Method and apparatus for multi-spectral analysis in noninvasive nir spectroscopy |
-
2000
- 2000-08-31 JP JP2001520083A patent/JP2003508744A/ja active Pending
- 2000-08-31 CA CA002383725A patent/CA2383725A1/fr not_active Abandoned
- 2000-08-31 WO PCT/CA2000/001000 patent/WO2001016577A1/fr not_active Application Discontinuation
- 2000-08-31 EP EP00955994A patent/EP1214577A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003508744A (ja) | 2003-03-04 |
| EP1214577A1 (fr) | 2002-06-19 |
| WO2001016577A1 (fr) | 2001-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6741876B1 (en) | Method for determination of analytes using NIR, adjacent visible spectrum and discrete NIR wavelenths | |
| CA2383725A1 (fr) | Procede de determination d'analytes au moyen d'un spectre en proche infrarouge, d'un spectre visible adjacent et de longueurs d'ondes distinctes de spectre en proche infrarouge | |
| EP0630203B1 (fr) | Dispositif non invasif et methode pour determiner les concentrations de differents composants du sang ou des tissus | |
| US6741875B1 (en) | Method for determination of analytes using near infrared, adjacent visible spectrum and an array of longer near infrared wavelengths | |
| US7343185B2 (en) | Measurement of body compounds | |
| US5361758A (en) | Method and device for measuring concentration levels of blood constituents non-invasively | |
| US5137023A (en) | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography | |
| EP1478265B1 (fr) | Spectraphotometrie a impulsion active | |
| KR100893432B1 (ko) | 조직 샘플 중의 표적 분석 물질 특성의 비침습적 측정방법 및 이를 위한 장치 | |
| CA2383727A1 (fr) | Procede de determination d'analytes au moyen d'un spectre visible adjacent, a infrarouge proche et reseau de longueurs d'onde plus longues a infrarouge proche | |
| US8406839B2 (en) | Method and apparatus for determining blood analytes | |
| AU749033B2 (en) | Apparatus and method for noninvasive glucose measurement | |
| EP0828533B1 (fr) | Procede et appareil permettant l'evaluation rapide et non invasive des parametres de la composition sanguine | |
| JP2000515778A (ja) | 体液成分レベルの生体内測定および制御のための埋込可能センサーおよびシステム | |
| US20070110621A1 (en) | Method and apparatus for measuring analytes | |
| JP2004279427A (ja) | 目的物の成分濃度測定方法及び装置 | |
| US8523785B2 (en) | Method and apparatus for measuring analytes | |
| Liu et al. | Next step of non-invasive glucose monitor by NIR technique from the well controlled measuring condition and results | |
| EP2319394A1 (fr) | Dispositif et procédénon invasive pour la surveillance des analytes contenus dans des échantillons biologiques | |
| Davies-Shaw et al. | New light upon non-invasive blood glucose monitoring |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |